When sourcing bulk Ivermectin, it is critical to ensure the product complies with international pharmacopoeia standards such as USP (United States Pharmacopeia), BP (British Pharmacopeia), or EP (European Pharmacopoeia). Suppliers must provide a Certificate of Analysis (COA) for every batch, detailing purity levels (typically ≥98%), residual solvents, and heavy metal content. Furthermore, the manufacturer should hold a valid GMP (Good Manufacturing Practice) certificate and, ideally, a CEP (Certificate of Suitability) or DMF (Drug Master File) to facilitate regulatory filings in the destination country.